ORIC — ORIC Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $543.72m
- $335.54m
- 31
- 23
- 72
- 37
Annual cashflow statement for ORIC Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -26.9 | -73.7 | -78.7 | -89.1 | -101 |
| Depreciation | |||||
| Non-Cash Items | 1.1 | 25.4 | 14.2 | 13.5 | 9.08 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.22 | 2.04 | 4.07 | -0.445 | 4.9 |
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -23.5 | -45.3 | -59.5 | -75.1 | -85.7 |
| Capital Expenditures | -0.768 | -0.667 | -0.939 | -2.08 | -0.849 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | -215 | 159 | -107 | -42.6 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.768 | -216 | 158 | -109 | -43.4 |
| Financing Cash Flow Items | -0.099 | -21.2 | -1.85 | -0.399 | -0.227 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 70.8 | 251 | 49.1 | 25.2 | 85.7 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 46.5 | -10.7 | 148 | -159 | -43.4 |